SC 13G/A

SCHEDULE 13G AMENDMENT - OXIGENE, INC.

Company: Oncotelic Therapeutics, Inc.
Filed: January 10, 2011
Accession Number: 0000929638-11-000011

View Document ↗ View on SEC.gov ↗